Cargando…

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Karagianni, Anna, Malamatari, Maria, Kachrimanis, Kyriakos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874831/
https://www.ncbi.nlm.nih.gov/pubmed/29370068
http://dx.doi.org/10.3390/pharmaceutics10010018
_version_ 1783310240957071360
author Karagianni, Anna
Malamatari, Maria
Kachrimanis, Kyriakos
author_facet Karagianni, Anna
Malamatari, Maria
Kachrimanis, Kyriakos
author_sort Karagianni, Anna
collection PubMed
description Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct pharmaceutical interest, along with their in vitro properties and available in vivo data and characterization techniques are discussed, highlighting the potential of cocrystals as an attractive route for drug development.
format Online
Article
Text
id pubmed-5874831
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58748312018-04-02 Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs Karagianni, Anna Malamatari, Maria Kachrimanis, Kyriakos Pharmaceutics Review Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct pharmaceutical interest, along with their in vitro properties and available in vivo data and characterization techniques are discussed, highlighting the potential of cocrystals as an attractive route for drug development. MDPI 2018-01-25 /pmc/articles/PMC5874831/ /pubmed/29370068 http://dx.doi.org/10.3390/pharmaceutics10010018 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Karagianni, Anna
Malamatari, Maria
Kachrimanis, Kyriakos
Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
title Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
title_full Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
title_fullStr Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
title_full_unstemmed Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
title_short Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
title_sort pharmaceutical cocrystals: new solid phase modification approaches for the formulation of apis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874831/
https://www.ncbi.nlm.nih.gov/pubmed/29370068
http://dx.doi.org/10.3390/pharmaceutics10010018
work_keys_str_mv AT karagiannianna pharmaceuticalcocrystalsnewsolidphasemodificationapproachesfortheformulationofapis
AT malamatarimaria pharmaceuticalcocrystalsnewsolidphasemodificationapproachesfortheformulationofapis
AT kachrimaniskyriakos pharmaceuticalcocrystalsnewsolidphasemodificationapproachesfortheformulationofapis